Cargando…
Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy
INTRODUCTION: The spleen is a lymphoid organ and we hypothesize that clinical benefit to immunotherapy may present with an increase in splenic volume during treatment. The purpose of this study was to investigate whether changes in splenic volume could be observed in those showing clinical benefit v...
Autores principales: | Castagnoli, Francesca, Doran, Simon, Lunn, Jason, Minchom, Anna, O’Brien, Mary, Popat, Sanjay, Messiou, Christina, Koh, Dow-Mu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262211/ https://www.ncbi.nlm.nih.gov/pubmed/35797413 http://dx.doi.org/10.1371/journal.pone.0270950 |
Ejemplares similares
-
Relative fat fraction of malignant bone lesions from breast cancer, prostate cancer and myeloma are significantly lower than normal bone marrow and shows excellent interobserver agreement
por: Castagnoli, Francesca, et al.
Publicado: (2023) -
Early Response to Chemotherapy in Malignant Pleural Mesothelioma Evaluated Using Diffusion-Weighted Magnetic Resonance Imaging: Initial Observations
por: Curcean, Sebastian, et al.
Publicado: (2021) -
Improving real‐world myeloma patient access to whole body MRI through “open‐access” knowledge sharing: The UK experience
por: Kaiser, Martin F, et al.
Publicado: (2020) -
Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases
por: Donners, Ricardo, et al.
Publicado: (2023) -
Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyond
por: Joshi, Kroopa, et al.
Publicado: (2021)